Free Influenza vaccine in 2018 for children aged 6 months to less than 5 years
In Victoria in 2018 the Influenza vaccine will be provided FREE for all children aged 6 months to less than 5 years of age. For further information and how to access the vaccine please head to our MVEC Free Influenza vaccine for children in 2018 reference page
Thinking about getting your child the Influenza vaccine?
With the roll out of the 2018 Influenza vaccine the following article may help provide some clarification regarding immunising children
The Conversation: thinking about getting your child the flu vaccine?
For further information regarding the Influenza vaccine please refer to our page MVEC: Influenza vaccine recommendations
Menveo® (Meningococcal A, C, W, Y) vaccine shortage
GSK has announced that there is a current shortage in the supply of Menveo® vaccine for the remainder of 2018. Refer to the TGA announcement for further information. For alternate Meningococcal immunisation options please see our MVEC: Meningococcal disease and vaccines page
Influenza 2018
MVEC has now updated it's Influenza recommendations for the 2018 season. Please follow the link for further information MVEC: Influenza vaccine recommendations
Changes to the No Jab, No Play legislation
As of February 28 2018, changes to the "No Jab, No Play" legislation have come into effect. Only Immunisation History statements provided by the Australian Immunisation Register (AIR) will be the accepted proof of immunisation. Previous forms of documentation (eg GP letter or local council statement) will not be accepted. For further information refer to MVEC's No Jab No Play reference page.
Influenza vaccine and egg allergy update
Based on the latest guidelines from the Australiasian Society of Clinical Immunology and Allergy, influenza vaccines can be safely administered in community vaccination clinics (which may or may not have direct medical practitioner supervision) to those with and without egg allergy (including egg anaphylaxis). This is a single dose, followed by the recommended 15 minute observation period. Please refer to our MVEC: Allergy and Immunisation page for further details.
Introduction of Gardasil 9
With the transition from Gardasil® to Gardasil 9® on the National Immunisation Program in January 2018, MVEC has created a new Immunisation Reference page on Human Papilloma Virus (HPV). Please follow the link for details MVEC: Human Papilloma Virus (HPV)
AEFICAN.ORG.AU the new national surveillance website
We would like to advise you that the SAEFVIC website address has changed to aefican.org.au which is a national surveillance website
*Please note saefvic.org.au will be temporarily redirected to the new aefican.org.au website.
- Your existing login details will still work on this new website so there is no need to reregister**.
- Upon signing in you will be automatically directed to the Victorian, SAEFVIC arm which continues to only be accessible by SAEFVIC staff.
- There is no change to our reporting or follow up services so please continue to report as usual.
New Users
For new users of aefican.org.au you will need to register via the Register tab on the homepage. Please enter email address, create password and all other required fields. Subsequent logins will be via the Login tab entering username and selected password. Once logged in your details will be auto filled on the Reporter details page.
If you have any queries you can contact us on 1300 882 924 (Option 1) or [email protected]
Regards,
The SAEFVIC team
**For those reporters who live interstate and registered a non-Victorian address, you will need to re-register with a Victorian address. The new AEFI-CAN system is state-based so automatically directs users to the portal for the state/territory registered in their account.
The Clinical Vaccinology Update is back!
The CVU is back and will be held on Tuesday 28th November 2017 at Monash University in Caulfield. To book your tickets to the CVU, head to our events page.
New Zoster vaccine (Zostavax®) FAQs reference page
SAEFVIC has updated its Zoster resources and developed a new frequently asked questions (FAQ) page for use by providers. The Zoster vaccine FAQs page provides answers to questions on the use of Zostavax® and can be used in conjunction with existing resources in the Zoster MVEC page.